Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

June 12, 2022

Frontline nivolumab and ipilimumab combination therapy was associated with increased 5-year survivorship in patients with metastatic non–small cell lung cancer—regardless of PD-L1 expression.

June 24, 2016

Although we as healthcare providers want to be cautious and not provide a sense of false hope, we can also acknowledge that for individuals who are deeply religious and spiritual, terminal illness that results in death may not be viewed as negative.

February 20, 2016

Collaboration to feature content from one of nation’s leading nursing school programs.

February 19, 2016

Racial and ethnic minority populations in the United States continue to experience higher cancer mortality rates than those among non-minority populations.